Lepu Biopharma Co., Ltd. (2157.HK) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Lepu Biopharma Co., Ltd., with annual and quarterly history.
| Metric | 2025 |
|---|---|
| Valuation | |
| P/E Ratio | 31.89x |
| P/B Ratio | 5.65x |
| P/S Ratio | 8.60x |
| Profitability | |
| Gross Margin | 80.4% |
| Operating Margin | 9.6% |
| Net Margin | 28.0% |
| EBITDA Margin | 19.6% |
| Liquidity | |
| Current Ratio | 0.98x |
| Quick Ratio | 0.94x |
| Leverage | |
| Debt/Equity | 0.76x |
YoY = year-over-year change. Source: FMP..